BOUDRY, Switzerland--(BUSINESS WIRE)--Celgene International Sàrl (NASDAQ: CELG) today announced that clinical investigators from leading hematology research centers around the world will present data from recent and on-going clinical trials of multiple Celgene products at the 50th Annual American Society of Hematology Meeting and Exposition from December 6-9, 2008 in San Francisco, California. Nearly 130 posters and presentations will report important new findings in indications such as multiple myeloma, non-Hodgkin’s lymphoma, chronic lymphocytic leukemia, myelodysplastic syndromes, amyloidosis and myelofibrosis.
